These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10419130)

  • 21. In-vitro study of the activity of ciprofloxacin alone and in combination against strains of Pseudomonas aeruginosa with multiple antibiotic resistance.
    Davies GS; Cohen J
    J Antimicrob Chemother; 1985 Dec; 16(6):713-7. PubMed ID: 2936706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.
    Bauernfeind A
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():111-7. PubMed ID: 19810172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New antimicrobial agent series XVII: Ceftazidime].
    Ishibiki K
    Jpn J Antibiot; 1986 Nov; 39(11):2819-30. PubMed ID: 3102806
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug resistance and floral distribution of Pseudomonas aeruginosa].
    Jia CY
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1990 Sep; 6(3):170-3, 236. PubMed ID: 2125852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of ceftazidime by avibactam against β-lactam-resistant Pseudomonas aeruginosa in an in vitro infection model.
    Sy SK; Zhuang L; Beaudoin ME; Kircher P; Tabosa MA; Cavalcanti NC; Grunwitz C; Pieper S; Schuck VJ; Nichols WW; Derendorf H
    J Antimicrob Chemother; 2017 Apr; 72(4):1109-1117. PubMed ID: 28077672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa.
    Philippon A; Paul G; Nevot P
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():119-22. PubMed ID: 19810173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
    Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
    J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.
    Sader HS; Castanheira M; Mendes RE; Flamm RK; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2015; 59(6):3656-9. PubMed ID: 25845861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro.
    Barclay ML; Begg EJ; Chambers ST; Peddie BA
    J Antimicrob Chemother; 1996 Nov; 38(5):853-8. PubMed ID: 8961055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant β-Lactam Resistance Mechanisms.
    Torrens G; Cabot G; Ocampo-Sosa AA; Conejo MC; Zamorano L; Navarro F; Pascual Á; Martínez-Martínez L; Oliver A
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6407-10. PubMed ID: 27480848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
    Sader HS; Huband MD; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of sulperazon against recent isolates of ceftazidime-resistant bacteria.
    Lim VK; Halijah MY
    Med J Malaysia; 2001 Sep; 56(3):365-9. PubMed ID: 11732084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the in vitro activity of ceftazidime: in culture, in serum and in combination with granulocytes].
    Daschner FD; Bassler M; Grundau D; Dieterle L; Just HM
    Immun Infekt; 1983 Nov; 11(6):221-8. PubMed ID: 6439624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of piperacillin, ceftazidime, cefepime and cefpirome against Pseudomonas aeruginosa strains with intrinsic ticarcillin resistance.
    Bert F; Setbon PG; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1996; 42(6):426-31. PubMed ID: 8957576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transduction of resistance to Imipenem, Aztreonam and Ceftazidime in nosocomial strains of Pseudomonas aeruginosa by wild-type phages.
    Blahová J; Hupková M; Babálová M; Krcméry V; Schäfer V
    Acta Virol; 1993 Dec; 37(6):429-36. PubMed ID: 8010181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam.
    Kresken M; Körber-Irrgang B
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899002
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential resistance of hospital Pseudomonas aeruginosa to ceftazidime, imipenem or aztreonam.
    Krcméry V; Antal M; Menkyna R; Knothe H; Schäfer V
    J Chemother; 1989 Jul; 1(4 Suppl):364-5. PubMed ID: 16312441
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of antibiotics against resistant Pseudomonas aeruginosa.
    Fujita J; Negayama K; Takigawa K; Yamagishi Y; Kubo A; Yamaji Y; Takahara J
    J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.